Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
about
Preconception Prebiotic and Sitagliptin Treatment in Obese Rats Affects Pregnancy Outcomes and Offspring Microbiota, Adiposity, and Glycemia.Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen.Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and FutureDietary Nutrients, Proteomes, and Adhesion of Probiotic Lactobacilli to Mucin and Host Epithelial Cells
P2860
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
@ast
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
@en
type
label
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
@ast
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
@en
prefLabel
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
@ast
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
@en
P2860
P356
P1476
Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development
@en
P2093
Nelly Amenyogbe
Rym Ben-Othman
P2860
P356
10.3389/FPED.2017.00111
P577
2017-05-24T00:00:00Z